MSTVIM
XBI icon

Messner & Smith Theme Value Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Messner & Smith Theme Value Investment Management’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-445
Closed -$24K – 94
2016
Q2 		$24K Hold
445
– – 0.04% 67
2016
Q1 		$23K Buy
+445
New +$23.1K 0.05% 64

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $2.41B AUM 286.33% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Messner & Smith Theme Value Investment Management's XBI Position: Q3 2016 in Review

Messner & Smith Theme Value Investment Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2016, closing a stake of 445 shares — an estimated $24K sold.

Messner & Smith Theme Value Investment Management first reported a position in XBI in Q1 2016 and held it in 2 quarters. The position peaked at $24K in Q2 2016. 228 funds tracked by Wall St. Rank hold XBI as of Q3 2016.

  • Messner & Smith Theme Value Investment Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2016 after selling out during the quarter.
  • Messner & Smith Theme Value Investment Management sold 445 State Street SPDR S&P Biotech ETF shares in Q3 2016, an estimated $24K.
  • Messner & Smith Theme Value Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2016 and held it in 2 quarters.
  • Messner & Smith Theme Value Investment Management's State Street SPDR S&P Biotech ETF position peaked at $24K in Q2 2016.
  • 228 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2016.

Based on Messner & Smith Theme Value Investment Management's 13F filing for Q3 2016, filed 10 Nov 2016.